U
UTMD icon

UBS’s Utah Medical Products UTMD Stock Holding History

UBS’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$75K Buy
+1,532
New +$77.8K ﹤0.01% 6347
2014
Q1 		– Sell
-3
Closed – – 10837
2013
Q4 		$0 Buy
+3
New +$165 ﹤0.01% 10789
2013
Q3 		– Sell
-529
Closed -$29K – 10737
2013
Q2 		$29K Buy
+529
New +$24.9K ﹤0.01% 7433

Other funds holding UTMD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
MDCM
Morgan Dempsey Capital Management Menomonee Falls, Wisconsin $220M AUM 18.32% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

UBS's UTMD Position: Q3 2014 in Review

UBS opened a new position in Utah Medical Products (UTMD) in Q3 2014: 1,532 shares worth $75K. The stake represents ﹤0.01% of the portfolio and ranks #6347 among its holdings. This is a return to the name: UBS previously reported a position in UTMD as recently as Q4 2013.

UBS first reported a position in UTMD in Q2 2013 and has held it in 3 quarters since. 62 funds tracked by Wall St. Rank hold UTMD as of Q3 2014.

  • UBS held 1,532 shares of Utah Medical Products worth $75K as of Q3 2014.
  • Utah Medical Products was a new UBS position in Q3 2014.
  • Utah Medical Products made up ﹤0.01% of UBS's portfolio in Q3 2014, its #6347 holding.
  • UBS first reported a position in Utah Medical Products in Q2 2013 and has held it in 3 quarters since.
  • 62 funds tracked by Wall St. Rank held Utah Medical Products as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.